Document Detail


HIV Impairment of Immune Responses in Dendritic Cells.
MedLine Citation:
PMID:  22975877     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Dendritic cells and their subsets are diverse populations of immune cells in the skin and mucous membranes that possess the ability to sense the presence of microbes and orchestrate an efficient and adapted immune response. Dendritic cells (DC) have the unique ability to act as a bridge between the innate and adaptive immune responses. These cells are composed of a number of subsets behaving with preferential and specific features depending on their location and surrounding environment. Langerhans cells (LC) or dermal DC (dDC) are readily present in mucosal areas. Other DC subsets such as plasmacytoid DC (pDC), myeloid DC (myDC), or monocyte-derived DC (MDDC) are thought to be recruited or differentiated in sites of pathogenic challenge. Upon HIV infection, DC and their subsets are likely among the very first immune cells to encounter incoming pathogens and initiate innate and adaptive immune responses. However, as evidenced during HIV infection, some pathogens have evolved subtle strategies to hijack key cellular machineries essential to generate efficient antiviral responses and subvert immune responses for spread and survival.In this chapter, we review recent research aimed at investigating the involvement of DC subtypes in HIV transmission at mucosal sites, concentrating on HIV impact on cellular signalling and trafficking pathways in DC leading to DC-mediated immune response alterations and viral immune evasion. We also address some aspects of DC functions during the chronic immune pathogenesis and conclude with an overview of the current and novel therapeutic and prophylactic strategies aimed at improving DC-mediated immune responses, thus to potentially tackle the early events of mucosal HIV infection and spread.
Authors:
Zahra Ahmed; Magdalena Czubala; Fabien Blanchet; Vincent Piguet
Related Documents :
23302777 - Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of end...
23853427 - Cytokines in sepsis: potent immunoregulators and potential therapeutic targets-an updat...
23781227 - Pathogenicity of and plant immunity to soft rot pectobacteria.
24531847 - Knockdown of microrna-155 in kupffer cells results in immunosuppressive effects and pro...
22047207 - Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular response...
21959047 - Egfr inhibitors sensitize non-small cell lung cancer cells to trail-induced apoptosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  762     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  2013  
Date Detail:
Created Date:  2012-09-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  201-38     Citation Subset:  IM    
Affiliation:
Department of Dermatology and Wound Healing, Institute of Infection and Immunity, Cardiff University School of Medicine and University of Hospital Wales, Heath Park, Cardiff, Wales, CF14 4XN, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interactions Between HIV-1 and Innate Immunity in Dendritic Cells.
Next Document:  HIV-Derived Vectors for Gene Therapy Targeting Dendritic Cells.